Publicaciones en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (17)

2022

  1. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study

    BMJ open, Vol. 12, Núm. 3, pp. e050110

2021

  1. Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2578-2585

  2. Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1422-1430

  3. Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia

    International Journal of Infectious Diseases, Vol. 110, pp. 36-44

2020

  1. Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial

    BMJ open, Vol. 10, Núm. 6, pp. e036416

  2. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial

    Trials, Vol. 21, Núm. 1

  3. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2018

  1. Estimated glomerular filtration rate is an early biomarker of cardiac surgery-associated acute kidney injury

    Nefrologia, Vol. 38, Núm. 6, pp. 596-605

  2. Pulse oximetry screening for critical congenital heart defects

    Cochrane Database of Systematic Reviews, Vol. 2018, Núm. 3

2015

  1. Diagnostic accuracy of pulse oximetry screening for critical congenital heart defects

    Cochrane Database of Systematic Reviews, Vol. 2015, Núm. 10

2014

  1. Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation

    Health and Quality of Life Outcomes, Vol. 12, Núm. 1

  2. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study

    Journal of Cystic Fibrosis, Vol. 13, Núm. 6, pp. 716-722

  3. Individual variability in finger-to-finger transmission efficiency of Enterococcus faecium clones

    MicrobiologyOpen, Vol. 3, Núm. 1, pp. 128-132

  4. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients

    Cochrane Database of Systematic Reviews, Vol. 2014, Núm. 9

2013

  1. In Vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 spanish hospitals: Establishing the validity of standard broth microdilution as susceptibility testing method

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 11, pp. 5701-5703

2012

  1. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: A systematic review and meta-analysis

    The Lancet, Vol. 379, Núm. 9835, pp. 2459-2464

2011

  1. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients

    Clinical Microbiology and Infection, Vol. 17, Núm. 5, pp. 704-711